PLA2G4A Antikörper (C-Term)
Kurzübersicht für PLA2G4A Antikörper (C-Term) (ABIN470612)
Target
Alle PLA2G4A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Detects endogenous levels of total human cPLA2. Does not cross-react with the secreted PLA2 (sPLA2) or cytosolic Ca2+ independent PLA2 (iPLA2). Species cross-reactivity: Human, mouse and rat.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide (KLH coupled) corresponding to the C-terminal residues of human cPLA2.
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, IP (1:50), WB (1:1000)
Usage: Suitable for use in ELISA, Western Blot and Immunoprecipitation. Western Blot: 1:1000. Immunoprecipitation: 1:50. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM HEPES, pH 7.5, 150 mM sodium chloride, 0.1 mg/mL BSA, 50 % glycerol. No preservative added.
-
Konservierungsmittel
- Without preservative
-
Handhabung
- avoid freeze thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- PLA2G4A (Phospholipase A2, Group IVA (Cytosolic, Calcium-Dependent) (PLA2G4A))
-
Andere Bezeichnung
- cPLA2
-
Pathways
- Inositol Metabolic Process, G-protein mediated Events, VEGF Signaling
Target
-